These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12829920)

  • 1. Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys.
    Bîrsan T; Hausen B; Higgins JP; Hubble RW; Klupp J; Stalder M; Celniker A; Friedrich S; O'Hara RM; Morris RE
    Transplantation; 2003 Jun; 75(12):2106-13. PubMed ID: 12829920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro.
    Vierboom MP; Ossevoort M; Sick EA; Haanstra K; Jonker M
    Transpl Immunol; 2003; 11(2):215-22. PubMed ID: 12799206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys.
    Hausen B; Klupp J; Christians U; Higgins JP; Baumgartner RE; Hook LE; Friedrich S; Celnicker A; Morris RE
    Transplantation; 2001 Sep; 72(6):1128-37. PubMed ID: 11579312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates.
    Haanstra KG; Ringers J; Sick EA; Ramdien-Murli S; Kuhn EM; Boon L; Jonker M
    Transplantation; 2003 Mar; 75(5):637-43. PubMed ID: 12640302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of rapamycin and co-stimulation blockade using anti-B7 antibodies in renal allotransplantation in baboons.
    Boulday G; Ashton-Chess J; Bernard P; Karam G; Vié H; Moreau A; Minault D; Lorré K; Soulillou JP; Blancho G
    Nephrol Dial Transplant; 2004 Jul; 19(7):1752-60. PubMed ID: 15069178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86.
    Kagaya F; Hori J; Kamiya K; Kaji Y; Oshika T; Amano S; Yamagami S; Tsuru T; Tanaka S; Matsuda H; Yagita H; Okumura K
    Exp Eye Res; 2002 Jan; 74(1):131-9. PubMed ID: 11878826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis.
    Tsai MK; Ho HN; Chien HF; Ou-Yang P; Lee CJ; Lee PH
    Transplantation; 2004 Jan; 77(1):48-54. PubMed ID: 14724434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term limb allograft survival using a short course of anti-CD45RB monoclonal antibody, LF 15-0195, and rapamycin in a mouse model.
    Zhong T; Liu Y; Jiang J; Wang H; Temple CL; Sun H; Garcia B; Zhong R; Ross DC
    Transplantation; 2007 Dec; 84(12):1636-43. PubMed ID: 18165776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.
    Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K
    Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies.
    Delmonico FL; Knowles RW; Colvin RB; Cavender DE; Kawai T; Bedle M; Stroka D; Preffer FI; Haug C; Cosimi AB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):784-5. PubMed ID: 8438479
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
    Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
    Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of CTLA-4Ig and sirolimus on orthotopic lung-allograft survival and histology.
    Ugurlu MM; Griffin MD; Tazelaar HD; McGregor CG
    Transplantation; 2003 Aug; 76(3):489-95. PubMed ID: 12923433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient blocking of both B7.1 (CD80) and B7.2 (CD86) in addition to CD40-CD40L interaction fully abrogates the immune response following systemic injection of adenovirus vector.
    Ziller C; Stoeckel F; Boon L; Haegel-Kronenberger H
    Gene Ther; 2002 May; 9(9):537-46. PubMed ID: 11973629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
    Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
    Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival.
    Tinubu SA; Hakimi J; Kondas JA; Bailon P; Familletti PC; Spence C; Crittenden MD; Parenteau GL; Dirbas FM; Tsudo M
    J Immunol; 1994 Nov; 153(9):4330-8. PubMed ID: 7930631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies.
    Lee J; Lee EN; Kim EY; Lee HJ; Park HJ; Sun CL; Lee SK; Joh JW; Lee KW; Kwon GY; Kim SJ
    Transplant Proc; 2005; 37(1):123-5. PubMed ID: 15808569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
    Li J; Xia J; Zhang K; Xu L
    J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent CD8+ CTLs detected in anti-CD4 (OKT4A) MAb immunosuppressed cynomolgus recipients with prolonged allograft survival.
    Wee S; Kawai T; Knowles R; Colvin R; Cosimi AB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):794-5. PubMed ID: 8438484
    [No Abstract]   [Full Text] [Related]  

  • 19. TIRC7 is induced in rejected human kidneys and anti-TIRC7 mAb with FK506 prolongs survival of kidney allografts in rats.
    Kumamoto Y; Tamura A; Volk HD; Reinke P; Löhler J; Tullius SG; Utku N
    Transpl Immunol; 2006 Nov; 16(3-4):238-44. PubMed ID: 17138060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel fully human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys.
    Imai A; Suzuki T; Sugitani A; Itoh T; Ueki S; Aoyagi T; Yamashita K; Taniguchi M; Takahashi N; Miura T; Shimamura T; Furukawa H; Todo S
    Transplantation; 2007 Oct; 84(8):1020-8. PubMed ID: 17989608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.